Innovation and opportunity for chimeric antigen receptor targeted T cells
Author:
Publisher
Elsevier BV
Subject
Cancer Research,Transplantation,Cell Biology,Genetics(clinical),Oncology,Immunology,Immunology and Allergy
Reference75 articles.
1. Human T cell responses against melanoma;Boon;Annu Rev Immunol,2006
2. Adoptive transfer of costimulated T cells induces lymphocytosis in patients with relapsed/refractory non-Hodgkin lymphoma following CD34+-selected hematopoietic cell transplantation;Laport;Blood,2003
3. Costimulated tumor-infiltrating lymphocytes are a feasible and safe alternative donor cell therapy for relapse after allogeneic stem cell transplantation;Hardy;Blood,2012
4. A phase 1 trial of donor lymphocyte infusions expanded and activated ex vivo via CD3/CD28 costimulation;Porter;Blood,2006
5. Tumor vaccines and beyond;Melenhorst;Cytotherapy,2011
Cited by 10 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Chimeric antigen receptor-T cells targeting epithelial cell adhesion molecule antigens are effective in the treatment of colorectal cancer;BMC Gastroenterology;2024-08-06
2. Latest advances in chimeric antigen receptor T-cell immunotherapy and future directions;4TH INTERNATIONAL CONFERENCE ON FRONTIERS OF BIOLOGICAL SCIENCES AND ENGINEERING (FBSE 2021);2022
3. CAR T Cells: Precision Cancer Immunotherapy;The Indonesian Biomedical Journal;2018-12-28
4. Bespoke cell therapy manufacturing platforms;Biochemical Engineering Journal;2018-04
5. Chimeric Antigen Receptor T Cells: Self-Replicating Drugs for Cancer;Current Drug Targets;2017-01-24
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3